News

2017-11-13

PRESS RELEASE: Ascelia Pharma strengthens its board of directors to support international expansion

Ascelia Pharma is strengthening its current board of directors with the addition of Helena Wennerström and Hans Maier as the company prepares to continue its growth journey.

2017-10-30

PRESS RELEASE: Ascelia Pharma strengthens its oncology product portfolio

CMC Contrast AB acquires Oncoral Pharma Aps to further strengthen its product portfolio within oncology. In connection with the acquisition, the company is re-named to Ascelia Pharma AB.